In Ex parte Michalek, Attraction No. 2023-004204 (PTAB Dec. 27, 2024), the Patent Trial and Attraction Board (PTAB) evaluated an invention involving medical well being know-how and synthetic intelligence. The PTAB particularly acknowledged that the patent claims at subject recited new details about the nexus between sure biomarkers and improvement of lung most cancers as facilitated by machine studying. In truth, previous to enchantment, the applicant had efficiently overcome all rejections below part 103. However, primarily based on Patent Workplace steering, the PTAB nonetheless decided the claims had been flawed from the attitude of material eligibility. Though the details on this resolution concern medical well being innovation, the choice is useful to tell patent technique for AI enabled innovations throughout varied disciplines and industries.
Trending
- Can having soaked walnuts help reduce ‘bad’ cholesterol levels? | Health News
- Tiny Bookshop review – a truly cosy escape made with readers in mind | Games
- Rig Up Any Camera, Anywhere With Another Helpful Cine-Style Halo Kit For All Camera Sizes
- Boies Schiller sanctioned nearly $15K for ‘uniquely eye-opening breakdown in civility’
- LinkedIn Shares Strategic Insights for B2B Marketers [Infographic]
- The One Thing Google DeepMind CEO Says Is Missing for AGI
- Siri’s New Features May Include Adding Voice Controls to Apps
- Frankly, what have we learnt from Nicola Sturgeon’s memoir?